Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Birrer

Showing results (21-30 of 222) with videos related to

Pageof 23
Sort By:
Oncotarget|December 13, 2017
Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic targetTsun Yee Tsang, Wei Wei, Hiroaki Itamochi, et al.
Cancer Research|June 3, 2004
Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-JunMari Kielosto, Pirjo Nummela, Riikka Katainen, et al.
Cancer Research|January 21, 2006
Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblastsPirjo Nummela, Miao Yin, Mari Kielosto, et al.
Cancer Metastasis Reviews|December 29, 2014
Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategiesCesar M Castro, Hyungsoon Im, Christine Le, et al.
Molecular and Cellular Biology|March 31, 2005
p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cellsVirna D Leaner, Howard Donninger, Chad A Ellis, et al.
The Journal of Clinical Investigation|September 11, 2013
FGF18 as a prognostic and therapeutic biomarker in ovarian cancerWei Wei, Samuel C Mok, Esther Oliva, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Ovarian cancer: markers of responseYoung-Jeong Na, John Farley, Audrey Zeh, et al.
American Journal of Clinical Oncology|June 15, 2013
Advances in the management of recurrent endometrial cancerLeslie S Bradford, Jose Alejandro Rauh-Hain, John Schorge, et al.
Plos One|January 25, 2012
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancerVinod Vathipadiekal, Deepa Saxena, Samuel C Mok, et al.
Cancer Research|April 29, 2010
Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancerLídia Hernandez, Sarah C Hsu, Ben Davidson, et al.
Pageof 23

Showing results (21-30 of 222) with videos related to

Sort By:
Pageof 23
Oncotarget|December 13, 2017
Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic targetTsun Yee Tsang, Wei Wei, Hiroaki Itamochi, et al.
Cancer Research|June 3, 2004
Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-JunMari Kielosto, Pirjo Nummela, Riikka Katainen, et al.
Cancer Research|January 21, 2006
Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblastsPirjo Nummela, Miao Yin, Mari Kielosto, et al.
Cancer Metastasis Reviews|December 29, 2014
Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategiesCesar M Castro, Hyungsoon Im, Christine Le, et al.
Molecular and Cellular Biology|March 31, 2005
p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cellsVirna D Leaner, Howard Donninger, Chad A Ellis, et al.
The Journal of Clinical Investigation|September 11, 2013
FGF18 as a prognostic and therapeutic biomarker in ovarian cancerWei Wei, Samuel C Mok, Esther Oliva, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Ovarian cancer: markers of responseYoung-Jeong Na, John Farley, Audrey Zeh, et al.
American Journal of Clinical Oncology|June 15, 2013
Advances in the management of recurrent endometrial cancerLeslie S Bradford, Jose Alejandro Rauh-Hain, John Schorge, et al.
Plos One|January 25, 2012
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancerVinod Vathipadiekal, Deepa Saxena, Samuel C Mok, et al.
Cancer Research|April 29, 2010
Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancerLídia Hernandez, Sarah C Hsu, Ben Davidson, et al.
Pageof 23